Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Regencell Bioscience Holdings Limited (RGC) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 592.23 thousand shares as of 2024-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2025-10-31
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|
| 2024-06-30 | 592.23K shares 20-F · filed 2025-10-31 | ||
| 2022-06-30 | 15.59K shares 20-F · filed 2023-10-27 | ||
| 2021-06-30 | 1.24M shares 20-F · filed 2022-10-31 | ||
| 2021-06-09 | 46.76K shares 20-F · filed 2021-10-29 |